COVID-HEART
The main aims of this study are, for a UK population, to characterise the prevalence and extent of myocardial involvement from COVID-19 infection, to assess recovery status at 6 months, and to understand the impact on patient quality of life and functional capacity. As part of the COVID-HEART protocol, there is a blood biomarker and genetic sub-study which participants will have the option of participating in alongside the main study.
Contact Information
- Email:
- su47@leicester.ac.uk
- Telephone:
- 0116 204 4786
- Address:
-
University of Leicester
Cardiovascular Sciences
Glenfield General Hospital
Groby Road
Leicester
Leicestershire
LE3 9QP
England
Last Updated: 02/17/2021
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |